Sarah Calkin covers the performance and quality beat which incorporates patient safety and regulation with a particular focus on the Care Quality Commission. She covered the Mid Staffordshire Foundation Trust public inquiry and the subsequent fallout, giving her an insight into the major drivers of the current health policy environment. She also covers the NHS in the south west of England and is interested in the challenges of providing healthcare in a rural environment.Follow Sarah Calkin on Twitter @sjcalkin and on Google+
- Tel: 020 3033 2791
- E-mail: Sarah.email@example.com
NHS England has appointed the directors of most of the organisation’s new ‘sub regions’ which are to be created as part of a restructure designed to cut costs by 15 per cent.
WORKFORCE: The leader of a well respected clinical commissioning group has been appointed to the chief executive post of an acute trust under investigation by Monitor.
Clinical commissioning groups across England are mulling the use of an unlicensed drug which could save the NHS millions of pounds, HSJ has learned
- Beds could go under Somerset community services plans
- Concern over CCG dialysis transfer
- First of new NHS 111 contracts awarded
- New NHS England partnership with pharma to speed up drug access
- NEW Devon sets out service cut plans
- Patients 'denied treatments' because of 'Kafkaesque' commissioning regime
- Expensive drugs to be cut from cancer drugs fund